IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q2 Solutions from Quest Diagnostics (NYSE: DGX), the world leader in diagnostic information services, for $760 million, resulting in 100 percent ownership by IQVIA. Q2 Solutions is a leading global clinical laboratory services organization that provides comprehensive testing, project management, supply chain, biorepository and biospecimen and consent tracking solutions for clinical trials.
Read the full article: IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Diagnostics //
Source: https://www.businesswire.com/news/home/20210401005191/en/IQVIA-Acquires-Remaining-Interest-in-Q2-Solutions-from-Quest-Diagnostics-Raises-Full-Year-2021-Adjusted-Diluted-EPS-Guidance